286 related articles for article (PubMed ID: 11184047)
1. The price of pharmaceuticals given managed care health insurance membership.
Brotman BA
Pharm Pract Manag Q; 2000 Jul; 20(2):16-9. PubMed ID: 11184047
[TBL] [Abstract][Full Text] [Related]
2. Special report: the value of pharmaceuticals. Data watch. Managed care and prescription drugs.
Bus Health; 1991; [VALUE]():6-7. PubMed ID: 10116288
[No Abstract] [Full Text] [Related]
3. Managing prescription drug costs.
Sica JM
Empl Benefits J; 2001 Mar; 26(1):35-40. PubMed ID: 11272515
[TBL] [Abstract][Full Text] [Related]
4. Getting serious about generics.
Sipkoff M
Manag Care; 2003 Jan; 12(1):36-9. PubMed ID: 12575509
[No Abstract] [Full Text] [Related]
5. Firms help companies carve savings from drug spending.
Kenkel PJ
Mod Healthc; 1992 May; 22(21):34. PubMed ID: 10118148
[No Abstract] [Full Text] [Related]
6. Managed competition and the health care crisis.
Finkel ML
Health Care Manag; 1995 Oct; 2(1):43-50. PubMed ID: 10165641
[TBL] [Abstract][Full Text] [Related]
7. Perspectives. Drug formularies pose legal threat to providers.
Moskowitz DB
Faulkner Grays Med Health; 1995 Feb; 49(6):suppl 1-4. PubMed ID: 10139750
[No Abstract] [Full Text] [Related]
8. Health plans keeping drug cost increases in check with programs that promote generics.
Capitation Manag Rep; 2002 Jul; 9(7):101-3, 97. PubMed ID: 12164057
[TBL] [Abstract][Full Text] [Related]
9. Geography and destiny: local-market perspectives on developing Medicare Advantage regional plans.
Hurley RE; Strunk BC; Grossman JM
Health Aff (Millwood); 2005; 24(4):1014-21. PubMed ID: 16012141
[TBL] [Abstract][Full Text] [Related]
10. HMO and PPO growth and hospital utilization and payment: a recursive model.
Hu TW; Sullivan SD; Scheffler RM
Adv Health Econ Health Serv Res; 1992; 13():225-41. PubMed ID: 10129445
[TBL] [Abstract][Full Text] [Related]
11. By the numbers. The rising costs of prescription drugs.
Thornton D
Healthplan; 1999; 40(5):71-2. PubMed ID: 10622972
[No Abstract] [Full Text] [Related]
12. Rising health care costs: is this the turning point?
Tyler T; Alvey BA
Tenn Med; 1999 Jul; 92(7):255-6. PubMed ID: 10396173
[No Abstract] [Full Text] [Related]
13. Points to consider about prescription drug prices: an overview of federal policy and pricing studies.
Kucukarslan S; Hakim Z; Sullivan D; Taylor S; Grauer D; Haugtvedt C; Zgarrick D
Clin Ther; 1993; 15(4):726-38. PubMed ID: 8221823
[TBL] [Abstract][Full Text] [Related]
14. Decomposing pharmaceutical cost growth in different types of health plans.
Chernew ME; Smith DG; Kirking DM; Fendrick AM
Am J Manag Care; 2001 Jul; 7(7):667-73. PubMed ID: 11464425
[TBL] [Abstract][Full Text] [Related]
15. Less capitation equals higher costs in HMOs PPOs, says survey.
Capitation Manag Rep; 2003 Aug; 10(8):110-3, 105. PubMed ID: 12966696
[TBL] [Abstract][Full Text] [Related]
16. Competition in hospital and health insurance markets: a review and research agenda.
Morrisey MA
Health Serv Res; 2001 Apr; 36(1 Pt 2):191-221. PubMed ID: 11327174
[TBL] [Abstract][Full Text] [Related]
17. Highlights of the Medicare Prescription Drug Act.
Conomikes GS
J Okla State Med Assoc; 2005 Oct; 98(10):492-3. PubMed ID: 16296207
[No Abstract] [Full Text] [Related]
18. Weaker HMOs will seek concessions from hospitals for 2002 as medical cost rise.
Health Care Strateg Manage; 2001 Jun; 19(6):16-7, 1. PubMed ID: 11409092
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical insurance and the demand for prescription pharmaceuticals in Västerbotten, Sweden.
Rudholm N
Scand J Public Health; 2005; 33(1):50-6. PubMed ID: 15764241
[TBL] [Abstract][Full Text] [Related]
20. Perspectives. Wall Street verbatim: wider networks need not drive new cost explosion.
Cunningham R
Med Health; 1998 Jun; 52(25):suppl 1-4. PubMed ID: 10180838
[No Abstract] [Full Text] [Related]
[Next] [New Search]
